Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (1094)	3/18/2002 6:47:18 PM
From: tuck	Read Replies (1) \| Respond to of 1784

Before extensively plugging their own company (which part I snipped, as Trickle no longer follows VARI, as it sells too much to non-tricklish businesses) Varian execs made some general comments on the trickle market at PittCon: >>NEW ORLEANS--(BW HealthWire)--March 18, 2002--``Scientific instruments are not mired in a mature, slow-growth market as some report. Rather, this is an enormously innovative industry capable of providing double-digit growth for companies that target the right applications, with the right product solutions, all supported by a global support and distribution presence,'' said Allen J. Lauer, chairman and CEO of Varian, Inc. (Nasdaq:VARI - news). Lauer and senior vice president Garry Rogerson, who leads Varian's Scientific Instruments business, made their remarks today before securities analysts and journalists attending the 2002 Pittsburgh Conference on Applied Spectroscopy and Analytical Chemistry (Pittcon), the largest industry event serving the instrument marketplace. ``Scientific instruments are the indispensable tools at the foundation of many high-growth segments like proteomics, drug discovery, and pharmaceutical manufacture,'' continued Lauer. ``They are also critical to certain chemical analysis applications that are growing handsomely and are hungry for productivity-boosting analytical innovations. In fact, many instrument techniques used today in life science applications were proved out in chemical analysis settings. ``The current market situation is analogous to the booming environmental analysis market that began in the 1970s. Those companies investing in products that solved specific environmental challenges, and that could tailor them to the specific regulatory requirements of different regions, were well rewarded."<< snip Meaning it's a stock picker's market in Trickle, as it is everywhere, and as it always (late 99 early 00 excepted, perhaps) has been. And sure enough, ABI and MDZ slightly up, WAT down on the resolution of a patent battle that was unfavorable to the latter late Friday. Cheers, Tuck